Drugmaker Sun Pharma on Friday said its December quarter net profit doubled to Rs 1,852.5 crore.
The pharma major reported a net profit of Rs 1,852.5 crore in Q3FY21 compared with Rs 913.5 crore in the year-ago quarter.
Revenue grew 8.4 per cent year-over-year to Rs 8,837 crore compared with Rs 8,155 crore in Q3FY20.
Earnings before interest, taxes, depreciation, and amortisation (EBITDA) for the quarter under review was Rs 2,406.1 crore while the EBITDA margin stood at 27.2 per cent.
Sun Pharma reported other income of Rs 315 crore for the quarter against Rs 120 crore for the quarter-over-quarter.
Sun Pharma manufactures generics, branded generics, speciality, over-the-counter products, anti-retrovirals, active pharmaceutical ingredients (APIs) and intermediates.
more recommended stories
Rajasthan Royals vs Punjab Kings live score over Match 4 T20 16 20 updates
Match Reports Topics mentioned.
NEET PG Mock Test Expected To Be Released Soon
NEET PG mock test to be.
Indian Premier League, SRH vs KKR: Fans Unhappy With SRH’s Decision To Bench Kane Williamson For KKR Clash
SunRisers Hyderabad (SRH) began.
Sonia Gandhi Condoles Death Of Congress Candidate Madhava Rao In Tamil Nadu Polls
“A low profile and a hard-working.